WEC
LCTX icon

Winslow Evans & Crocker’s Lineage Cell Therapeutics LCTX Stock Holding History

Winslow Evans & Crocker’s Portfolio LCTX Stock Details LCTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-1,029
Closed -$2.83K – 1200
2017
Q2 		$2.83K Buy
+1,029
New +$2.88K ﹤0.01% 1142
2014
Q3 		– Sell
-13,629
Closed -$33.5K – 1414
2014
Q2 		$33.5K Buy
13,629
+6,195
+83% +$14K 0.01% 569
2014
Q1 		$19.7K Hold
7,434
– – 0.01% 678
2013
Q4 		$22K Buy
+7,434
New +$22.5K 0.01% 671

Other funds holding LCTX

BC
Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PGP
Prescott General Partners Boca Raton, Florida $1.37B AUM 23.81% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
DWM
Destination Wealth Management Walnut Creek, California $3.85B AUM 13% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return